MGMT and glioblastoma: Despite the fact that MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation results in its transcriptional silencing and increases chemosensitivity to temozolomide (TMZ) [26], the dismal prognosis associated with many primary glioblastomas without MGMT promoter methylation still has not changed with current therapies.